Histopathology of breast carcinoma following neoadjuvant systemic therapy: a common association between letrozole therapy and central scarring

J S J Thomas; H S Julian; R V Green; D A Cameron; M J Dixon

doi:10.1111/j.1365-2559.2007.02752.x

Histopathology of breast carcinoma following neoadjuvant systemic therapy: a common association between letrozole therapy and central scarring

J S J Thomas, H S Julian, R V Green, D A Cameron, M J Dixon

Research output: Contribution to journal › Article › peer-review

Abstract / Description of output

Neoadjuvant systemic therapy of large and locally advanced breast cancers may, through shrinkage, enable breast conservation surgery. Letrozole, an aromatase inhibitor, is used frequently in the treatment of oestrogen receptor-positive breast cancer. The aim was to examine the response patterns in a letrozole-treated group compared with a chemotherapy-treated group.

Original language	English
Pages (from-to)	219-26
Number of pages	8
Journal	Histopathology
Volume	51
Issue number	2
DOIs	https://doi.org/10.1111/j.1365-2559.2007.02752.x
Publication status	Published - Aug 2007

Keywords / Materials (for Non-textual outputs)

Adult
Aged
Aged, 80 and over
Antineoplastic Agents
Aromatase Inhibitors
Breast Neoplasms
Cicatrix
Female
Humans
Middle Aged
Neoadjuvant Therapy
Nitriles
Receptors, Estrogen
Triazoles

Access to Document

10.1111/j.1365-2559.2007.02752.x

Cite this

@article{437ec1e53711451f828f7518b0388a27,

title = "Histopathology of breast carcinoma following neoadjuvant systemic therapy: a common association between letrozole therapy and central scarring",

abstract = "Neoadjuvant systemic therapy of large and locally advanced breast cancers may, through shrinkage, enable breast conservation surgery. Letrozole, an aromatase inhibitor, is used frequently in the treatment of oestrogen receptor-positive breast cancer. The aim was to examine the response patterns in a letrozole-treated group compared with a chemotherapy-treated group.",

keywords = "Adult, Aged, Aged, 80 and over, Antineoplastic Agents, Aromatase Inhibitors, Breast Neoplasms, Cicatrix, Female, Humans, Middle Aged, Neoadjuvant Therapy, Nitriles, Receptors, Estrogen, Triazoles",

author = "Thomas, {J S J} and Julian, {H S} and Green, {R V} and Cameron, {D A} and Dixon, {M J}",

year = "2007",

month = aug,

doi = "10.1111/j.1365-2559.2007.02752.x",

language = "English",

volume = "51",

pages = "219--26",

journal = "Histopathology",

issn = "0309-0167",

publisher = "Wiley-Blackwell",

number = "2",

}

TY - JOUR

T1 - Histopathology of breast carcinoma following neoadjuvant systemic therapy

T2 - a common association between letrozole therapy and central scarring

AU - Thomas, J S J

AU - Julian, H S

AU - Green, R V

AU - Cameron, D A

AU - Dixon, M J

PY - 2007/8

Y1 - 2007/8

N2 - Neoadjuvant systemic therapy of large and locally advanced breast cancers may, through shrinkage, enable breast conservation surgery. Letrozole, an aromatase inhibitor, is used frequently in the treatment of oestrogen receptor-positive breast cancer. The aim was to examine the response patterns in a letrozole-treated group compared with a chemotherapy-treated group.

AB - Neoadjuvant systemic therapy of large and locally advanced breast cancers may, through shrinkage, enable breast conservation surgery. Letrozole, an aromatase inhibitor, is used frequently in the treatment of oestrogen receptor-positive breast cancer. The aim was to examine the response patterns in a letrozole-treated group compared with a chemotherapy-treated group.

KW - Adult

KW - Aged

KW - Aged, 80 and over

KW - Antineoplastic Agents

KW - Aromatase Inhibitors

KW - Breast Neoplasms

KW - Cicatrix

KW - Female

KW - Humans

KW - Middle Aged

KW - Neoadjuvant Therapy

KW - Nitriles

KW - Receptors, Estrogen

KW - Triazoles

U2 - 10.1111/j.1365-2559.2007.02752.x

DO - 10.1111/j.1365-2559.2007.02752.x

M3 - Article

C2 - 17650216

SN - 0309-0167

VL - 51

SP - 219

EP - 226

JO - Histopathology

JF - Histopathology

IS - 2

ER -

Histopathology of breast carcinoma following neoadjuvant systemic therapy: a common association between letrozole therapy and central scarring

Abstract / Description of output

Keywords / Materials (for Non-textual outputs)

Access to Document

Fingerprint

Cite this